Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer
Clinical trial NCT03651219 · UNKNOWN
Trial details
- NCT number
- NCT03651219
- Sponsor
- Beijing Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-08
- Primary completion
- 2019-08-08
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.